High-grade Neuroendocrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-14
Clinical Trial Update: A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs [Phase 2]
A Phase 2 clinical trial is evaluating etoposide-carboplatin with pembrolizumab and lenvatinib maintenance in high-grade neuroendocrine tumo…